These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The value of (neo-)adjuvant therapy in rectal carcinoma]. Ulrich A; Hartel M; Weitz J; Friess H; Büchler M Dtsch Med Wochenschr; 2004 Apr; 129(17):957-62. PubMed ID: 15083399 [No Abstract] [Full Text] [Related]
9. [Treatment of rectal cancer]. Rödel C; Bruch HP; Hofheinz R; Lang H; Arnold D Onkologie; 2010; 33 Suppl 4():19-23. PubMed ID: 20431308 [TBL] [Abstract][Full Text] [Related]
10. Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Rich TA; Ota D; Rosenthal SA; Minsky BD; Bader JL; Coia LR; Janjan NA; John MJ; Merrick GS; Raben D; Tepper JE; Saltz L; Leibel S Radiology; 2000 Jun; 215 Suppl():1473-80. PubMed ID: 11037560 [No Abstract] [Full Text] [Related]
11. Optimal staging and treatment of localised rectal cancer. Påhlman L Ann Oncol; 2002; 13 Suppl 4():251-5. PubMed ID: 12401698 [No Abstract] [Full Text] [Related]
12. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer. Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493 [TBL] [Abstract][Full Text] [Related]
13. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer? Petrelli NJ J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061 [No Abstract] [Full Text] [Related]
14. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008. Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934 [TBL] [Abstract][Full Text] [Related]
15. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450 [TBL] [Abstract][Full Text] [Related]
16. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation. Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458 [TBL] [Abstract][Full Text] [Related]
17. Current neoadjuvant strategies in rectal cancer. Julien LA; Thorson AG J Surg Oncol; 2010 Mar; 101(4):321-6. PubMed ID: 20187066 [TBL] [Abstract][Full Text] [Related]
18. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery. Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116 [TBL] [Abstract][Full Text] [Related]
20. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy. Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]